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Abstract 27 
Rabies virus (RABV) remains one of the most important global zoonotic pathogens. RABV 28 
causes rabies, an acute encephalomyelitis associated with a high rate of mortality in humans 29 
and animals and affecting different parts of the world, particularly in Asia and Africa. 30 
Confirmation of rabies diagnosis relies on laboratory diagnosis, in which molecular 31 
techniques such as detection of viral RNA by reverse transcription polymerase chain reac ion 32 
(RT-PCR) are increasingly being used. 33 
In this study, two real-time quantitative RT-PCR assays were developed for large-spectrum 34 
detection of RABV, with a focus on African isolates. The primer and probe sets were targeted 35 
highly conserved regions of the nucleoprotein (N) and polymerase (L) genes.  36 
The results indicated the absence of non-specific amplification and cross-reaction with a 37 
range of other viruses belonging to the same taxonomic family, i.e Rhabdoviridae, as well as 38 
negative brain tissues from various host species. Analytical sensitivity ranged between 100 to 39 
10 standard RNA copies detected per reaction for N-gene and L-gene assays, respectively. 40 
Effective detection and high sensitivity of these assays on African isolates showed that they 41 
can be successfully applied in general research and used in diagnostic process and epizootic 42 
surveillance in Africa using a double-check strategy. 43 
 44 
Keywords: Rabies virus (RABV), real-time RT-qPCR assays, molecular techniques, 45 
broad detection, Africa 46 
 47 
 48 
 49 
 50 
 51 
 52 
 53 
 54 
 55 
 56 
 57 
 58 
Page 3 of 28
Ac
ce
pte
d M
an
us
cri
pt
 
 
1. Introduction 59 
 60 
Rabies  is  a lethal and neglected zoonotic  disease  with  significant public  health  impact in  61 
many  parts  of  the  world,  especially  in  developing  countries (1, 2). Rabies can affect 62 
almost all mammals, including humans (3). Indeed, rabies causes at least 59,000 human 63 
deaths annually worldwide, with 36.4% of them occurring in Africa alone (1, 4). 64 
Human exposures occur mainly through dog bites and children are the most affected by the 65 
disease, with 4 out of every 10 deaths occurring in children under the age of 15 (3, 5). 66 
However, in some industrialized countries, rabies virus transmission was also reported 67 
through transplantation of organs from donors whose rabies infection had not been 68 
recognized. These cases of rabies virus transmission by tissues transplantation were mostly 69 
due to a long incubation period in the donor (6, 7, 8). 70 
Rabies is an incurable disease and clinical presentation in humans can be sometimes difficult 71 
to distinguish from encephalitis symptoms caused by other viral infections (9). In this context, 72 
laboratory diagnosis is essential to confirm the diagnosis (10). Moreover, the diagnosis of 73 
rabies is often confirmed late in the course of the disease or postmortem because prognosis 74 
depends on history of exposure and clinical findings, and timely and reliable diagnosis may be 75 
very important for the prevention of rabies in the relatives of the patient and the healthcare 76 
workers.  77 
This fatal encephalitis is caused by virus members of the Lyssavirus genus (order 78 
Mononegavirales, family Rhabdoviridae) including Rabies virus (RABV). RABV is a 79 
neurotropic enveloped pathogen encompassing a negative single-stranded RNA that is around 80 
12 kb (kilobases) in size. As for all lyssavirus members, the RABV genome encodes five 81 
proteins with the nucleoprotein (N), the phosphoprotein (P), the matrix protein (M), the 82 
glycoprotein (G) and the polymerase (L) separated by four non-coding intergenic regions 83 
(IGRS) of different lengths and surrounded by two untranslated regions (UTR) (5). In 84 
addition, RABV presents a wide range of animal host reservoir and a large genetic diversity, 85 
with particularly four phylogenetic groups circulating in Africa with Africa 1 and 4 lineages, 86 
and with Africa 2 and 3 clades (11, 12). Thus, diagnostic tools which are able to broadly 87 
detect RABV are required.  88 
Currently, the “gold standard” technique for confirming postmortem cases is the direct 89 
fluorescent antibody test (FAT) (13, 14). For intra-vitam diagnosis, this method can detect 90 
viral nucleocapsid antigens in tissues section of skin biopsies. However, viral antigens are 91 
often only detectable at the final phase of the disease and not always by the FAT. Also, this 92 
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technique presents limits in the case of ante-mortem non-neural sample material or 93 
decomposed tissues. Furthermore, repeated sampling of skin biopsies is not practical for 94 
improvement of sensitivity of the FAT (10, 14, 15). To overcome the limits of FAT, several 95 
conventional and hemi-nested reverse transcription polymerase chain reaction assays (RT-96 
PCR) targeting the N or L gene, have been developed (16, 17, 18, 19, 20, 21, 22) and widely 97 
applied for the intra-vitam diagnosis of human rabies routine diagnosis. Indeed, the N gene is 98 
the most conserved region among the RABV genome which is the reason for its frequent use 99 
as target for rabies virus diagnostic assays (23). Also, the L gene harbours highly conserved 100 
regions which have targeted for molecular detection (22, 24). Despite a higher sensitivity, 101 
hemi-nested RT-PCR presents some disadvantages in terms of workload, risk of 102 
contamination, and time. Thus, several real time molecular tests targeting the N or L gene 103 
have been developed to complement conventional diagnosis of rabies and rabies-related 104 
viruses (10, 21, 25, 26, 27, 28, 29, 30). However, none of them have been validated against 105 
African strains from a large diversity of geographical origins, except a recent study (31).  106 
In this paper, we describe the validation of two sensitive and specific real-time RT-PCR 107 
assays with TaqMan probes targeting conserved regions of the N and L genes, which were 108 
developed for broad detection of African RABV strains. The detection capacity on clinical 109 
specimens and sensitivity of the assays suggest their suitable application in human as well as 110 
veterinary diagnostic fields. The assays coul  complement and add value to existing methods. 111 
 112 
2. Materials and methods 113 
 114 
2. 1.  Primers and probes design 115 
Initially, in order to design an assay capable of detecting African RABV isolates, full length 116 
genome sequences of two Africa 2 isolates available on GenBank database, corresponding to 117 
DRV-NG11 (GenBank Ac. No. KC196743) and CAR_11/001h (GenBank Ac. No. 118 
KF977826), were used. Multiple alignments were carried out using clustalW algorithm 119 
implemented in the Mega 6.0 software (32). We selected conserved regions of the N gene and 120 
the L gene for development of two detection systems. Both primers and TaqMan probes were 121 
designed using Primer3web® software (version 4.0.0, Whitehead Institute for Biomedical 122 
Research). To avoid non-specific cross-reactions with others lyssaviruses, primers and probe 123 
were validated by BLAST analysis on NCBI. To ascertain their broad spectrum of detection, 124 
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all primers and probes were analyzed in silico with sequences of a large panel of isolates from 125 
different parts of Africa. Primers and probes were synthetized by TIBMol-Biol (Berlin, 126 
Germany).  127 
 128 
2. 2. Samples and viral RNA extraction 129 
A total of 16 RABV isolates from experimentally infected mouse brain tissues preserved in 130 
the archive of the national reference center for rabies virus (NRC-Rabies) at Institut Pasteur of 131 
Dakar, Senegal (NRC-Rabies IPD) and previously confirmed as rabies positive by FAT, was 132 
used in this study. In addition, 61 other RABV isolates from FAT-confirmed primary brain 133 
samples or experimentally infected mouse brain samples, provided by the NRC-Rabies at 134 
Institut Pasteur, Paris, France (NRC-Rabies IPP) (14), were also included. Furthermore, in 135 
order to assess the specificity of the two RABV detection assays, a panel of 20 primary brain 136 
specimens provided by NRC-Rabies IPP from a range of important animals for rabies virus 137 
transmission, and previously confirmed to be negative by FAT, was also tested. In addition, 138 
15 other major representatives of rhabdoviruses other than RABV and from the archive of 139 
NRC-Rabies IPD were also tested. Finally, 19 clinical specimens including skin biopsy, saliva 140 
and cerebrospinal fluid (CSF) samples received at NRC-Rabies IPP and collected from human 141 
patients suspected of rabies infection were evaluated with both of these molecular tools. All 142 
extractions from isolates provided by NRC-Rabies IPD were performed using the QIAamp® 143 
Viral RNA Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions. 144 
The RNA was suspended in a final volume of 60 µl elution buffer and kept at −80°C until 145 
testing. For samples and isolates provided by NRC-Rabies IPP, extraction and storage were 146 
performed as previously described (31). 147 
 148 
2. 3.   Real-time RT-PCR (RT-qPCR) assays 149 
A similar RT-qPCR protocol was used for the detection of both N and L genes. All samples 150 
were tested in duplicate and RT-qPCR was performed using the Quantitect Probe RT-PCR kit 151 
(Qiagen, Hilden, Germany) in a 20 µl reaction mixture containing 2x QuantiTect probe RT-152 
PCR master mix, 0.25 µl of QuantiTect RT mix, 400 nM PCR primers and 200 nM TaqMan 153 
probes and 5 µl of 1:10 diluted RNA in RNase-free water. Positive controls containing master 154 
mix with standard RNA of each system and negative controls consisting of master mix with 155 
sterile RNase-free water were included in each run. The reaction was carried out on a 7500 156 
Fast Real Time system cycler or on a 7500 Real Time system cycler (Applied Biosystems, 157 
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Foster City, US) using the following temperature profile: 1 cycle of reverse transcription at 158 
50°C for 10 min, 1 cycle of denaturation at 95°C for 15 min, followed by 40 cycles of 95°C 159 
for 15 s and 60°C for 1 min. The RT-qPCR reactions were analyzed using the 7500 software 160 
(v2.0.1).  161 
 162 
2. 4. Specificity testing 163 
The specificity, representing the probability that the assay gives a negative result without 164 
presence of the targeted nucleotide region, was calculated by the formula Sp = a / (a + c); 165 
where a is the number of true negatives samples and c is the number of false positives. The 166 
specificity was determined using a panel of FAT negative samples and a panel of non-RABV 167 
rhabdoviruses. 168 
 169 
2. 5. Analytical sensitivity assessment 170 
 171 
2. 5. 1.  Standard curves generation 172 
Plasmids were generated by inserting the amplified RT-qPCR amplicons into pCRII (Life 173 
Technologies, GmbH, Darmstadt) and standard RNAs were synthetized with T7 RNA-174 
polymerase by TIB MolBiol (Berlin, Germany) according to manufacturer’s 175 
recommendations.  176 
Serial 10-fold dilutions of standard RNAs, from 108 to 1 molecule, were prepared in RNase-177 
free water. Corresponding mean Cq (quantification cycle) values obtained per triplicates per 178 
standard dilution were then plotted proportionally to the logarithm of the input copy numbers 179 
to generate a quantitative standard. 180 
 181 
2. 5. 2. Analytical testing 182 
The quantitative standards were used to evaluate the diagnostic assays performances such as 183 
limit of detection (LOD), the coefficient of correlation (R2) and the amplification efficiency 184 
(E) values. The LOD value represents the concentration where at least 50% of replicates of 185 
each dilution were detected. A linear model regression test was performed using R (version 186 
3.0.2, The R Foundation for Statistical Computing) to determine the value of R2, indicating 187 
the goodness of regression. The E value was calculated with the formula E = 10(-1/slope)-1. 188 
Relative RABV genome copies in tested samples was calculated through the formula q= 189 
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10(Cq-b)/a; where a is the slope, b is the intercept from a standard curve of each specific 190 
target gene and Cq is the quantification cycle number. Furthermore, the Pearson correlation 191 
efficient where a coefficient of 1 represents a good correlation was also calculated. 192 
 193 
2. 5. 3. Determination of sensitivity 194 
The sensitivity is defined as the probability that an assay give positive results in the presence 195 
of specific target. This was calculated by the formula Se = d/ (d+b); where b represents the 196 
number of false negatives and d is the number of true positives. Positive and negative 197 
predictive values were also calculated by formulas PPV= d / (d+c) and NPV= a/ (b+a), 198 
where a is the number of true negatives samples and c is the number of false positives. 199 
Moreover, a ROC («Receiver Operating Characteristic») analysis was performed, using the 200 
statistical software XLSAT (Version 2015.5.01.23654, Copyright Addinsoft 1995-2015) to 201 
identify the threshold value below which the test should be considered positive. Accuracy of 202 
assays was measured by the area under the ROC curve (AUC) with 95% confidential interval 203 
(CI) of AUC. An area higher than 0.9 represents an excellent test and a value of 0.5, a 204 
worthless test (33, 34).  205 
Finally, the comparability between Cq values given by these two quantitative assays was 206 
assessed using a Bland-Altman analysis where the agreement between these two 207 
measurements was quantified by using a graphical approach. Statistical limits of agreement 208 
are calculated by using the mean and the standard deviation of the differences between assays 209 
with 95% CI (35).  210 
 211 
2. 5. 4. Repeatability and inter-laboratory concordance 212 
The inter-assay and intra-assay repeatability were determined by coefficients of variation 213 
(CVs) of Cq value. Indeed, RNA of the RABV isolate SA217695SEN was extracted and 214 
amplified 10 times in the same run, for the assessment of intra-assay repeatability and in 10 215 
different runs by the same operator, in the same laboratory to evaluate inter-assay 216 
repeatability. Inter-laboratory concordance was evaluated using a range of anonymous 217 
samples which have been initially received, extracted and analyzed at the NRC-R IPP in the 218 
framework of its participation in 2015 in an inter-laboratory trial organized by the European 219 
Union reference laboratory for rabies, which is located in Nancy, France (36). The test panel 220 
tested with the two newly developed RT-qPCR consisted of nine anonymous samples, either 221 
uninfected or infected with various lyssavirus species and which have been previously 222 
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extracted by NRC-R IPP and storage at -80°C until use. Details of this trial have been 223 
provided elsewhere (36).  224 
Results obtained with both of these tools were compared to previous RT-qPCR results of the 225 
NRC-R IPP in terms of Cohen’s kappa coefficient (k), which is measure of the agreement 226 
between two raters. Statistical analysis was performed using XLSAT where the statistical 227 
significance was set to p < 0.05. 228 
 229 
2. 5. 5. Comparison with conventional hemi-nested RT-PCR  230 
Suckling newborn-mices were inoculated experimentally by the RABV isolate 231 
SA217695SEN and a virus titer of 6.7 107 ID50/mL was obtained according to the method of 232 
Reed and Muench (1938) (37). Ten-fold serial dilutions of this virus stock were used to 233 
compare the sensitivity of the two RT-qPCR methods with that of a conventional hemi-nested 234 
RT-PCR (RT-hnPCR) in the conditions which have been previously described (22). 235 
 236 
2. 5. 6. Clinical sensitivity testing 237 
Testing of a collection of nineteen RABV-positive or negative specimens including CSF, 238 
saliva and biopsy skin, was also carried out in duplicate to confirm the reliability of the new  239 
L-gene RT-qPCR.  240 
 241 
 242 
3. Results 243 
 244 
3. 1. Primers analysis 245 
BLAST analysis of designed primers and probes showed high homology with target regions 246 
of RABV sequences available from GenBank database. In silico analysis also revealed limited 247 
number of mismatches for primers and probes with sequences from other parts of Africa 248 
belonging to lineage Africa 1 and clade Africa 2 (Supplementary
 Table A.1) (Supplementary 249 
Figures A.1 and A.2). The TaqMan probes were labeled 5’ FAM (6-carboxyfluorescein) / 3’ 250 
BlackBerry Quencher (BBQ) and details are listed in Table 1. 251 
 252 
3. 2. Specificity  253 
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In order to ensure the specificity of the new systems and to evaluate the occurrence of non-254 
specific cross-reactivity, 16 isolates previously characterized RABV field samples and 15 255 
different rhabdoviruses other than RABV species were tested in duplicate with both of the 256 
assays (Table 2). Fluorescent detection was obtained only with RABV isolates whereas non-257 
targeted viruses were not detected. These results suggested that the designed primer pairs and 258 
probes exhibited no cross-reactivity with other species of lyssavirus (with Mokola and Lagos 259 
bat lyssaviruses) or other rhabdoviruses (Table 2). The amplicons size for some RABV 260 
isolates detected with each system was verified by 2% agarose gel electrophores s and the 261 
amplified fragments were sequenced using the respective forward and reverse primers of the 262 
corresponding systems. A BLAST analysis of obtained sequences showed high identity rate 263 
with the target region of the RABV isolate CAR_11/001h (GenBank Ac. No. KF977826) 264 
belonging to the Africa 2 phylogenetic clade. Then, these primers and probes were highly 265 
selective for RABV detection. In addition, we analyzed a panel of 20 FAT-negative primary 266 
brain samples from different vertebrate hosts important in RABV transmission. All were 267 
negative with both assays and confirmed that specificity was complete (Supplementary Table 268 
A.2).  269 
 270 
3. 3. Analytical sensitivity  271 
Diagnostic test performances of the new assays were assessed using several parameters. 272 
Analytical curves generated showed a LOD of 100 and 10 copies per reaction obtained for N-273 
gene assay and L-gene assay, respectively with RABV isolate SA217695SEN (Figure 1).  274 
Regression line slope values were determined for N gene and L gene assays, with -3.08 and -275 
3.1, respectively, which are close to the optimal slope value of -3.3. Significant respective 276 
linear regression p-values of 1.833e-09 and 6.977e-12 for N gene and L gene assays, 277 
respectively, and coefficients of correlation (R2) values higher than 0.99 indicated the 278 
goodness of the regression lines. Furthermore, high efficiency values (E) were obtained with 279 
both of these assays. A Pearson correlation test between the two regression curves revealed a 280 
coefficient of 0.99 (p < 0.0001) suggesting that correlation between the Cq values obtained by 281 
both RT-qPCR methods was excellent (Figure 1). 282 
To ascertain the broad detection capacity of established assays, various RABV isolates from 283 
different parts of the world, were tested. Considering detection of African RABV isolates, the 284 
L-gene system was able to detect all isolates tested while the N-gene assay detected only 90% 285 
of strains giving no-fluorescence signal with four isolates belonging to Africa-1 lineage, 286 
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including isolates from Somalia (93002SOM and 93006SOM), Tanzania (96013TAN) and 287 
Morocco (87012MAR) (Table 3a). Furthermore, the L-gene system also detected 100% of 288 
tested isolates from other counties of the world. Considering these isolates, the N-gene assay 289 
had a limited detection scale (55%) with no fluorescence signal with 9 isolates from Poland 290 
(96140POL), Germany (92001GER), Saudi Arabia (87001ARS), Turkey (94009TUR), Laos 291 
(99008LAO), Afghanistan (02052AFG), Russia (91041RUS) and one skunk isolate from 292 
USA (91004USA) (Table 3b) (38).  293 
Results of all previous tests summarized in Table 4 were used for sensitivity determination 294 
and ROC analysis as previously described (39). A sensitivity of 100% and 78.70% (CI 95%; 295 
68.40-89.00%) was found for the RABV L-gene assay and RABV N-gene assay, respectively, 296 
when compared to the reference technique. In addition, a PPV of 100% for each assay and 297 
NPVs of 100% and 72.91% (CI 95%; 56.76-82.79%) for L gene assay and N gene assays 298 
were obtained respectively (Fischer’s exact test p < 0.0001). All previously FAT- negative 299 
samples provided an undetermined mean Cq value after 40 cycles. Based on the results of the 300 
ROC analysis, we determined a Cq of 39.70 as the cut-off value below which reactions are 301 
positives for the L-gene assay and the N-gene assay, considering a 95% confidence interval. 302 
A Cq value above these cut-off values or an undetectable Cq was considered negative. An 303 
AUC of 1 was determined for each assay revealing that the tests have an excellent accuracy 304 
(Figure 2). Furthermore, Bland-Altman plot analysis also reported a non-significant bias 305 
(mean difference) of 1.920±6.875 (95% limits of agreement: -11.56 to 15.40), demonstrating 306 
that these two methods are approximatively equivalent (Figure 3). 307 
Intra-run and inter-run CVs of 1.67 % and 2.20 %, respectively, were found for the RABV N-308 
gene assay while the RABV L-gene assay showed intra-run and inter-run CVs of 1.08 % and 309 
2.16 %, respectively; indicating that assays are robust and highly repeatable(Table 4). In 310 
addition, the k of 1±0.31 (95% CI; 0.38-1.61) indicates that assays are accurate, detecting 311 
only RABV strains and giving 100% concordance to previous results obtained by the NRC-R 312 
IPP using a RT-qPCR (31) with the same samples (p= 0.001), and concordant with the results 313 
expected for this inter-laboratory trial with RABV isolates (Table 5).  314 
Simultaneously, both RT-qPCR assays and conventional hemi-nested RT-PCR were 315 
performed as previously described (22) on 13 ten-fold dilutions of the RABV isolate 316 
SA217695SEN with a titer of 6.7 107 ID50/mL. The RABV L-gene assay detected until 317 
0.00067 ID50/mL, corresponding to 28 genome copies using the L-gene quantification 318 
equation. However, conventional hemi-nested RT-PCR and RABV N-gene assay presented a 319 
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detection limit of 6.7 ID50/mL, corresponding to 75 copies of genome using N-gene 320 
quantification equation (Table 6). 321 
The RABV L-gene RT-qPCR assay was selected as the most sensitive technique for detection 322 
of RABV and was thus applied for the screening of human clinical samples from patients 323 
suspected of rabies infection. The clinical detection of RABV RNA was analyzed in duplicate 324 
using a panel of human samples from the archive of the NRC-R IPP and which were 325 
previously tested using a RT-qPCR assay (31). Compared to the latter technique considered as 326 
the reference test, all 4 previous RABV-positive samples were correctly detected with RABV-327 
L TaqMan probe assay, whereas any cross-reactivity was detected with all 15 RABV-negative 328 
specimens. Thus, the proposed RABV-L gene assay gave a 100% concordan e to the previous 329 
diagnosis results obtained with the RT-qPCR assay performed by NRC-R IPP (31), 330 
demonstrating its effectiveness to detected RABV in clinical specimens with high sensitivity, 331 
and its suited use as diagnostic tool in human RABV cases (Table 7). 332 
 333 
 334 
4. Discussion 335 
Despite rapid and sensitive RABV methods developed in recent years (27, 28, 30, 31, 42), 336 
only a few of them have been validated for the detection of African RABV strains with a large 337 
diversity of origin (21, 30, 31). Development of rapid and suitable molecular diagnostic tools 338 
for large-scale detection RABV isolates is important for routine diagnostic testing and 339 
epidemiological surveillance, particularly in Africa where rabies remains endemic. In this 340 
study, we developed two TaqMan real-time assays for broad detection of African RABV 341 
isolates in samples and for intra-vitam diagnosis in humans and post-mortem diagnosis in 342 
animals. These assays are based on conserved regions on N and L RABV genes. 343 
Oligonucleotide sequences for each assay were designed for wide detectability of African 344 
RABV isolates (Table 1, Supplementary Figures A.1 and A.2) (22). Regarding the specificity 345 
assessment and their selectivity to detect RABV on a large range of samples, the new primers 346 
pairs and probes showed a high specific rate and no cross detection of other tested 347 
rhabdoviruses and none of the 6 other lyssaviruses species tested. These results were also 348 
confirmed by sequencing a selected number of amplicons obtained from positive results.  349 
Moreover, evaluation of the analytical sensitivity proved that assays can detect a low amount 350 
of RABV RNA with estimated LODs ranging from 100 to 10 copies of RNA target per 351 
reaction, which indicates that our assays are highly sensitives, similar to previously reported 352 
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assays for viral RNA detected by TaqMan real-time RT-PCR (21, 31, 40, 41, 42). In addition, 353 
the high coefficients of determination (R2) and very good efficiencies (E >100%) demonstrate 354 
that they can both be successfully applied to quantitative analysis of viral loads in tested 355 
samples infected with RABV.  356 
However, with the high genetic diversity of RABV, development of a single sensitive real 357 
time assay covering all widely known phylogroups remains a challenge (43, 27). During the 358 
validation of the N-gene and L-gene based RT-qPCR assays, the broad detection spectrum 359 
was assessed through a large panel of RABV isolates representing different continents, with a 360 
focus on African isolates. Indeed, African strains were detected by both assays with a high 361 
coverage rate, mainly with the L gene-based assay. Thus our assays offer good performances 362 
on detection of African isolates and could be a useful complement for a recent published 363 
method (31) which presents some limits in detection of RABV isolates from Senegal 364 
belonging to the Africa 2 clade. Evaluation of the broad detection performance of our assays 365 
on isolates from other regions of the world displayed an excellent coverage level of the 366 
RABV L-gene RT-qPCR, whereas the RABV N-gene assay was limited with important non-367 
African RABV strains. The reduced sensitivity of the N-gene assay despite good in silico 368 
profiles and performance demonstrated by the assays could be explained with the presence of 369 
secondary structure formation of the target area which may make it less accessible for the N-370 
gene oligonucleotides during the RT-step (44, 45). All the RABV isolates tested (61 isolates 371 
belonging to the phylogenetic lineage cosmopolitan and clades Africa 2 and 3) were 372 
successfully detected, mainly with the L gene-based assay which provides a test with a large 373 
spectrum of RABV detection.  374 
Although in the comparative analysis, the L gene-based assay offered better performances 375 
than the N-gene assay regarding sensitivity and predictive values, it seems reasonable to 376 
perform a double-check strategy on tested samples, using both assays in order to increase 377 
reliability during use in routine rabies identification or epidemiological surveys as previously 378 
reported for others lyssaviruses (46, 31). Moreover, high AUC value found in ROC analysis 379 
predicted that both assays are useful for accurate detection of RABV in positive samples. 380 
Furthermore, the assays showed a good agreement between measurements as shown by the 381 
Bland-Altman analysis results, confirming their ability to be used efficiently for RABV 382 
detection. Additionally, inter-assay and intra-assay variability below 3% and strong inter-383 
laboratory concordance results ensure the repeatability and the RABV specificity of the two 384 
assay systems. Our assays, particularly the L-gene based assay, could be used accurately in 385 
different geographical contexts for RABV detection.  386 
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We used ten-fold dilutions of the RABV isolate SA217695SEN with a titer of 6.7 107 387 
ID50/mL and obtained with L-gene assay lower LOD value than with the hemi-nested RT-388 
PCR (22), although it has to be confirmed with a larger panel of isolates. The L-gene based 389 
assay was able to detect RABV with as low as 6.7 10-4 ID50/mL and could be successfully 390 
applied in RABV diagnostic process, particularly on decomposed material or samples with 391 
low viral load (15, 47). Furthermore, compared to the hemi-nested RT-PCR, the established 392 
RT-qPCRs offer some important advantages in reduction of workload and run time, while 393 
providing a higher sensitivity compared to the conventional RT-PCR. 394 
Based on its better performances, the L gene-based assay was chosen for determination of the 395 
detection capacity with clinical specimens in comparison with a previously existing RT-qPCR 396 
(31) considered as the reference technique. We evaluated the usefulness of the L-gene based 397 
assay for the intra-vitam diagnosis of rabies in human using a collection of positive and 398 
negative specimens including skin biopsy, saliva and cerebro-spinal fluid. Compared to the 399 
RT-qPCR assay from the NRC-R IPP (31) considered as the reference test, our L-gene based 400 
assay provided a strong concordance and the sensitivity was also high. This technique could 401 
be useful in clinical diagnostic as reliable quantitative tools for ante-mortem rabies diagnosis 402 
in humans (22, 31).  403 
Finally our assays, particularly the L-gene based assay, could be a complement for existing 404 
methods for rabies diagnosis (21, 31, 46, 48, 49) with a high specificity, sensitivity and 405 
repeatability and more suitable for broad detection of African RABV strains. 406 
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 565 
Figure 1: Standard curves of the TaqMan RT-qPCR assays using RABV-nucleoprotein gene-566 
specific probe (N) and RABV-polymerase gene-specific probe (L). The slope equation, the 567 
correlation coefficient (R2) and the efficiency (E) of each linear regression curve are shown in 568 
the figure. These standard curves were established using the RABV isolate SA217695SEN, 569 
and results are indicated as RNA copy number detected per reaction. 570 
 571 
 
572 
 573 
 574 
 575 
Figure 2: ROC curves of the developed assays using XLSTAT. The AUC value of 1 576 
indicate that the assays have excellent accuracy for RABV genome when samples are 577 
positives. 578 
 
579 
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 580 
Figure 3: Bland-Altman graphic of differences between N-gene and L-gene assays 581 
plotted against average Cq values of the two measurements. The bias of 1.920±6.875 (CI 582 
95%; -11.56 - 15.40) units is represented by the gap between X axis (zero differences) and the 583 
line of equality (blue) parallel to the X axis. 584 
 585 
 586 
 587 
Figure 4: Broad detection spectrum of news RABV assays. The countries where tested strains 588 
originated are colored in yellow, showing a significant detection scale of established RABV 589 
N-gene and L-gene diagnostic assays.   590 
 591 
 592 
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Table	1:	Oligonucleotide	sequences	of	primers	and	probes	designed	in	this	study
Name Type Length Sense Sequence	5'‐3' Gene Positiona GC	(%)		 Tm	(°C)b		 Product	Size	(nt)
RABVRPN1 primer 20 Sense GCTCTGGGCTGGTGTCGTTC Nucleoprotein 707‐726 65.00 58.87
RABVPN probe 23 Sense 6FAM‐CGAGCCARGGCAGGAGACTGCGG‐‐BBQ Nucleoprotein 819‐841 73.91 67.74 193
RABVFPN2 primer 20 Antisense TACGGGGACTTCCCGCTCAG Nucleoprotein 880‐899 65.00 59.14
RABVRPL1 primer 20 sense GGTTTCCGGDGCYGTDCCTC Polymerase 9472‐9491 65.00 58.94
RABVPL probe 27 sense 6FAM‐CCCGTCAYATAGGGTCRGCTCARGGGC‐‐BBQ Polymerase 9561‐9587 66.66 67.36 208
RABVFPL2 primer 20 Antisense CCTAGGGGAGACYTTGCCRT Polymerase 9660‐9679 65.00 59.02
FAM,	fluorescein	amidite;	BBQ,	blackberry	quencher;		
a,	corresponding	nucleotide	positions	of	RABV	strain	CAR_11/001h	(GenBank	Ac.	No.	KF977826)
b,	melting	temperature	(°C)
nt,	nucleotides
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Table	2:	Description	and	results	of	rhabdoviruses	isolates	used	in	this	study	for	Specificity	assessment
Isolates Virus Genus References Place	of	isolation year	of	isolation Species 	Mean	Cq	valuea SD 	Mean	Cq	valuea SD
SA221203SEN Rabies	(RABV) Lyssavirus from	CRORA	database Senegal 2011 Mellivora	capensis	 (honey	badger) 23.40 0.078 18.05 0.312
SA217694SEN Rabies	(RABV) Lyssavirus from	CRORA	database Senegal 2011 Canis	lupus	familiaris	 (dog) 18.40 0.432 19.99 0.114
SA217695SEN Rabies	(RABV) Lyssavirus from	CRORA	database Senegal 2011 Canis	lupus	familiaris	 (dog) 16.81 0.015 19.24 0.099
SA217750SEN Rabies	(RABV) Lyssavirus from	CRORA	database Senegal 2011 Canis	lupus	familiaris	 (dog) 17.31 0.191 21.89 0.467
SA218152SEN Rabies	(RABV) Lyssavirus from	CRORA	database Senegal 2011 Canis	lupus	familiaris	 (dog) 23.16 0.142 21.74 0.099
SH155966SEN Rabies	(RABV) Lyssavirus from	CRORA	database Senegal 2001 Homo	sapiens	 (human) 18.20 0.015 18.73 0.184
SH177846SEN Rabies	(RABV) Lyssavirus from	CRORA	database Senegal 2005 Homo	sapiens	 (human) 30.23 0.156 35.26 0.000
SA194858SEN Rabies	(RABV) Lyssavirus from	CRORA	database Senegal 2008 Canis	lupus	familiaris	 (dog) 17.18 0.008 20.37 0.219
SA204014SEN Rabies	(RABV) Lyssavirus from	CRORA	database Senegal 2010 Canis	lupus	familiaris	 (dog) 25.16 0.121 14.86 0.128
SA206776SEN Rabies	(RABV) Lyssavirus from	CRORA	database Senegal 2010 Canis	lupus	familiaris	 (dog) 25.15 0.015 15.00 0.036
SA252888SEN Rabies	(RABV) Lyssavirus from	CRORA	database Senegal 2013 Canis	lupus	familiaris	 (dog) 26.75 0.099 20.26 0.425
SA252913SEN Rabies	(RABV) Lyssavirus from	CRORA	database Senegal 2013 Canis	lupus	familiaris	 (dog) 23.52 0.114 16.39 0.057
SA262037SEN Rabies	(RABV) Lyssavirus from	CRORA	database Senegal 2013 Canis	lupus	familiaris	 (dog) 25.15 0.170 24.16 0.396
SA262503SEN Rabies	(RABV) Lyssavirus from	CRORA	database Senegal 2014 Canis	lupus	familiaris	 (dog) 23.22 0.057 21.01 0.071
SA262518SEN Rabies	(RABV) Lyssavirus from	CRORA	database Senegal 2014 Canis	lupus	familiaris	 (dog) 22.77 0.078 21.21 0.538
SA267115SEN Rabies	(RABV) Lyssavirus from	CRORA	database Senegal 2014 Canis	lupus	familiaris	 (dog) 22.46 0.368 22.62 0.142
DakAnB1094 Kolongo	(KOLV) unassigned JX276998 Central	African	Republic 1970 Euplectes	afra	 (bird) Neg Neg Neg Neg
AnY1307 Mokola	(MOKV) Lyssavirus NC_006429 Cameroon 1973 Crocidura	spp.	 (shrews) Neg Neg Neg Neg
AnB373d Sandjimba	(SJAV) unassigned JX277024 Central	African	Republic 1970 Acrocephalus	schoenobaenus 	(bird) Neg Neg Neg Neg
AnB4289 Nasoule	(NASV) unassigned JX277012 Central	African	Republic 1973 Andropadus	virens	 (bird) Neg Neg Neg Neg
AnD42443 Lagos	Bat	(LBV)	3 Lyssavirus NC020807 Senegal 1985 Eidolon	helvum	 (fruit	bat) Neg Neg Neg Neg
AnB672 Lagos	Bat	(LBV)	2 Lyssavirus from	CRORA	database Central	African	Republic 1974 Micropteropus	pusillus	 (fruit	bat) Neg Neg Neg Neg
An	K	6909 Lagos	Bat	(LBV)	4 Lyssavirus from	CRORA	database Guinea 1985 Nycteris	gambiensis	 (Gambian	Slit‐faced	Bat) Neg Neg Neg Neg
LBVNIG1956 Lagos	Bat	(LBV)	6 Lyssavirus EF547431 Nigeria 1956 Eidolon	helvum	 (fruit	bat) Neg Neg Neg Neg
DakHD763 Le	Dantec	(LDV) Ledantevirus AY854650 Senegal 1965 Homo	sapiens	 (human) Neg Neg Neg Neg
DakAnD5314 Keuraliba	(KEUV) Ledantevirus JX276996 Senegal 1968 Tatera	kempi		 (gerbil) Neg Neg Neg Neg
ArD89384 Chandipura	(CHNV) Vesiculovirus from	CRORA	database Senegal 1992 Phlebotomus	sp.	(sandflies) Neg Neg Neg Neg
SudAr1275 Obodhiang	(OBOV) Ephemerovirus HM856902 Sudan 1963 Mansonia	uniformis	 (mosquitoes) Neg Neg Neg Neg
ArY31‐65 Nkolbisson	(NKOV) Ledantevirus JX277015 Cameroon 1965 Eretmapodites	leucopus	 (mosquitoes) Neg Neg Neg Neg
DakAnB439 Garba	(GARV) unassigned KM204982 Central	African	Republic 1970 Corythornis	cristata	 (bird) Neg Neg Neg Neg
SAAr1995 Mossuril	(MOSV) Hapavirus KM204993 Mozambique 1959 Culex	sitiens	 (mosquitoes) Neg Neg Neg Neg
SD:	standard	deviation
Neg:	negative;	no	cross‐reactitvity
CRORA:	WHO	Reference	Centre	for	 Arboviruses	and	Hemorragic			 Fevers;	Institut	Pasteur,	 BP	220,	Dakar,	Senegal	
a:	Mean	Cq	value	from	duplicates
Rabies	virus	 Rabies	virus	
N	gene L	gene
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Table	3a:	Results	of	evaluation	of	Spectrum	of	detection	in	Africa
N	gene	assay 	L	gene	assay
Isolate Origin Species Year reference Phylogenetic	clade	‐	subclade Mean	Cq	valuea SD Mean	Cq	valuea SD
93012MAU Mauritania dog 1993 KX148237 Africa‐2 27.35 0.685 31.39 0.049
93011MAU Mauritania dog 1993 KX148236 Africa‐2 16.83 1.180 26.30 0.615
91031MAU Mauritania dog 1991 NRC‐Rabies	IPP Africa‐2 16.21 1.660 25.22 0.289
90024GUI Guinea dog 1990 KX148244 Africa‐2 17.28 0.000 23.32 0.028
92038CI Ivory	Coast dog 1992 KX148233 Africa‐2 21.56 0.098 23.93 0.148
90003CI Ivory	Coast dog 1990 NRC‐Rabies	IPP Africa‐2 17.82 0.042 22.24 0.113
90026CI Ivory	Coast dog 1990 NRC‐Rabies	IPP Africa‐2 16.32 0.487 26.03 0.926
01007CI Ivory	Coast dog 2001 KX148235 Africa‐2 14.85 0.289 22.06 1.385
92037CI Ivory	Coast dog 1992 KX148232 Africa‐2 23.23 0.120 24.46 1.046
95047HAV Burkina	Faso dog 1995 KX148230 Africa‐2 15.88 0.070 16.30 0.572
86036HAV Burkina	Faso dog 1986 KX148234 Africa‐2	 11.78 0.127 17.65 0.615
90012NIG Niger dog 1990 KX148229 Africa‐2 19.045 0.289 20.18 0.014
90010NIG Niger dog 1990 KX148231 Africa‐2 14.235 0.388 17.35 0.247
86070NGA Nigeria dog 1986 NRC‐Rabies	IPP Africa‐2 26.4 0.028 23.31 1.520
86003BRE Nigeria dog 1986 KX148201 Cosmopolitan	–	AF1a 26.15 0.226 22.41 0.763
95002	CAM Cameroon dog 1994 KX148242 Africa‐2 15.41 0.197 16.75 0.028
88003CAM Cameroon dog 1987 KX148243 Africa‐2 17.93 0.028 19.14 0.077
88006CAM Cameroon dog 1987 NRC‐Rabies	IPP Africa‐2 18.38 1.350 21.46 0.622
96009TCH Chad dog 1996 KX148241 Africa‐2 13.96 0.063 18.06 0.275
92018TCH Chad dog 1992 NRC‐Rabies	IPP Africa‐2 24.36 0.296 23.78 0.544
97138TCH Chad dog 1997 NRC‐Rabies	IPP Africa‐2 15.07 0.707 20.9 0.098
90021TCH Chad dog 1990 KX148240 Africa‐2 15.49 0.021 17.70 0.968
86097BEN Benin Cat 1986 KX148107 Africa‐2 15.10 0.021 17.23 0.056
94289RWA Rwanda dog 1994 KX148205 Cosmopolitan	–	AF1b 28.74 0.021 22.23 0.134
92028CAR Central	African	Republic dog 1992 NRC‐Rabies	IPP Cosmopolitan	–	AF1b 26.42 0.197 28.1 0.395
92029CAR Central	African	Republic dog 1992 KX148208 Cosmopolitan	–	AF1b 23.68 0.544 21.72 1.046
86031MOZ Mozambique dog 1986 KX148203 Cosmopolitan	–	AF1a 26.73 0.346 16.29 0.268
87021AFS South	Africa Human 1981 KX148103 Cosmopolitan	–	AF1b 27.69 0.346 21.12 0.197
92030NAM Namibia dog 1992 KX148204 Cosmopolitan	–	AF1b 22.91 0.806 14.66 0.339
86092EGY Egypt Human 1979 KX148101 Cosmopolitan	–	AF4 25.90 0.021 26.36 0.063
95049GAB Gabon dog 1995 KX148202 Cosmopolitan	–	AF1a 30.14 0.417 25.02 0.155
93002SOM Somalia dog 1993 KX148198 Cosmopolitan	–	AF1a Neg Neg 25.47 0.311
96013TAN Tanzania dog 1996 KX148206 Cosmopolitan	–	AF1b Neg Neg 19.75 2.008
93006SOM Somalia Jackal 1993 KX148199 Cosmopolitan	–	AF1a Neg Neg 22.40 0.120
87012MAR Morocco dog 1987 NRC‐Rabies	IPP Cosmopolitan	–	AF1a Neg Neg 33.39 0.141
88008ETH Ethiopia dog 1988 KX148200 Cosmopolitan	–	AF1a 28.11 0.240 23.99 0.113
04031MAR Morocco dog 2004 KX148195 Cosmopolitan	–	AF1a 26.13 0.007 20.09 0.113
90016MAR Morocco dog 1990 KX148196 Cosmopolitan	–	AF1a 27.78 0.219 22.62 0.240
98002MAD Madagascar Human 1998 KX148210 Cosmopolitan	–	AF1c 24.77 0.162 28.52 0.155
15005AFS South	Africa Mongoose 2014 NRC‐Rabies	IPP Africa‐3 23.78 0.601 31.34 0.049
15002AFS South	Africa Mongoose 2014 KX148221 Africa‐3 25.24 0.014 21.06 0.728
Neg:	negative	or	no	fluorescence	signal
Cq	:	quantitative	Cycle	number
a:	Mean	Cq	value	from	duplicates
SD:	standard	deviation
Determination	of	clades	and	subclades	were	done	according	to	Troupin	C,	et	al.,	 submitted	(38)	
NRC‐Rabies	IPP:	National	Reference	Renter	for	rabies	virus	database	at	Institut	Pasteur,	Paris,	France	
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Table	3b:	Results	of	evaluation	of	Spectrum	of	detection	in	other	parts	of	the	world
N	gene	assay 	L	gene	assay
Isolates Origin Species Year Reference Phylogenetic	clade	‐	subclade 	Mean	Cq	valuea SD 	Mean	Cq	valuea SD
91047FRA France Fox 1991 KX148127 Cosmopolitan	–	WE 27.11 0.162 22.73 0.155
96002FRA France Fox 1996 KX148126 Cosmopolitan	–	WE 27.38 0.077 20.41 1.301
96140POL Poland Raccoon	dog 1993 KX148120 Cosmopolitan	–	CE Neg Neg 16.31 0.106
92001GER Germany Fox 1991 KX148135 Cosmopolitan	–	WE Neg Neg 22.68 0.289
93039EST Estonia Raccoon	dog 1991 KX148149 Cosmopolitan	–	NEE 35.35 0.353 22.33 0.049
86054YOU Bosnia	and	Herzegovina Wolf 1986 KX148145 Cosmopolitan	‐	EE 37.08 0.353 25.54 0.007
87001ARS Saudi	Arabia Fox 1987 NRC‐Rabies	IPP Cosmopolitan	–	ME1a Neg Neg 33.08 0.183
94009TUR Turkey Dog 1993 KX148165 Cosmopolitan	–	ME2 Neg Neg 26.22 0.000
94272PHI Philippines Dog 1994 KX148259 Asian	–	SEA4 31.25 0.084 32.22 0.127
99009BUR Burma Dog 1999 NRC‐Rabies	IPP ND 19.15 0.007 33.4 0.183
99008CBG Cambodia Dog 1999 KX148252 Asian	–	SEA3 32.05 0.007 36.51 0.014
99010LAO Laos Dog 1999 KX148255 Asian	–	SEA3 Neg Neg 29.60 0.459
02043CHI China Dog ND NRC‐Rabies	IPP Asian	–	SEA2a 36.55 0.070 36.11 1.096
02045CHI China Dog ND NRC‐Rabies	IPP Asian	–	SEA2a 32.28 0.905 35.91 0.100
91014MEX Mexico Dog 1991 KX148110 Cosmopolitan	–	AM2a Neg Neg 21.32 0.353
86001BRE Brazil Dog 1986 KX148216 Cosmopolitan	–	AM3a 19.04 0.007 27.42 0.063
91001USA USA Skunk 1982 KX148213 Cosmopolitan	–	AM1 35.61 0.339 20.81 0.141
91004USA USA Skunk 1991 KX148224 Arctic‐related	–	A Neg Neg 23.64 0.480
02052AFG Afghanistan Dog 2002 KX148225 Arctic‐related	–	AL1b Neg Neg 22.40 0.028
91041RUS Russia Fox 1991 NRC‐Rabies	IPP Cosmopolitan	–	CA1 Neg Neg 23.18 1.011
Neg:	negative	or	no	fluorescence	signal
Cq	:	quantitative	Cycle	number
a:	Mean	Cq	value	from	duplicates
SD:	standard	deviation
Determination	of	clades	and	subclades	were	done	according	to	Troupin	C,	et	al.,	 submitted	(reference	38)	
NRC‐Rabies	IPP:	National	Reference	Renter	for	rabies	virus	database	at	Institut	Pasteur,	Paris,	France	
ND:	not	determined
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Table	4:	Results	of	repeatability	test	and	summary	of	results	used	for	determination	of	Analytical	specificity	and	sensitivity	
N	GENE	ASSAY L	GENE	ASSAY
Intra‐run	CV 1.67	%	 1.08	%	
Inter‐run	CV 2.20	%,	 2.16	%,	
Positive	samples Negative	samples Positive	samples Negative	samples
Positive 64 0 77 0
Negative 13 35 0 35
TOTAL 77 35 77 35
Specificty	 100% 100%
Sensitivity	 78.70%	(CI	95%;	68.40‐89.00%)	 100%
Positive	Predictive	Value	(PPV) 100% 100%
Negative	Predictive	Value	(NPV) 72.91%	(CI	95%;	56.76‐82.79%)	 100%
%:	percentage
All	samples	were	previously	tested	by	the	reference	technique,	FAT	
CV:	coefficient	of	variation
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Table	5:	Description	of	isolates	used	and	results	of	inter‐laboratory	concordance	
Interlaboratory	trial NRC‐R	IPP NRC‐R	IPD NRC‐R	IPD
Identification Isolate virus Spieces Origin Year Expected	resultsa Combo	RT‐qPCR		 	N‐gene	assay	 	L‐gene	assay	
1 CVS	27	13‐14 RABV	(rabies	virus) Fixed	strain / / Positive Positive Positive Positive
2 GS7	18‐13 RABV	(rabies	virus) Vulpes	vulpes France 1986 Positive Positive Positive Positive
3 GREECE	03‐15 RABV	(rabies	virus) Vulpes	vulpes Greece 2012 Positive Positive Positive Positive
4 BBLV	02‐15 BBLV	(Bokeloh	bat	lysssavirus) Myotis	natterreri France 2012 Positive Positive Negative Negative
5 DUVV	02‐12 DUVV	(Duvenhage	virus	) Homo	sapiens	sapiens South	Africa 1971 Positive Positive Negative Negative
6 EBL‐1a	08‐14 EBLV‐1	(European	Lagos	bat	virus	1) Eptesicus	serotinus France 2002 Positive Positive Negative Negative
7 EBL‐2	01‐15 EBLV‐2	(European	Lagos	bat	virus	2) Myotis	daubentonii United	kingdom 2004 Positive Positive Negative Negative
8 Negative	17‐13 / Vulpes	vulpes France 2012 Negative Negative Negative Negative
9 Negative	17‐13 / Vulpes	vulpes France 2012 Negative Negative Negative Negative
a:	Expected	results	by	European	Union	Reference	Laboratory	for	Rabies	during	interlaboratory	trial	2015	(36).			
Assays	detected	only	RABV	strains	and	gave	results	100%	concordant	with	previous	results	obtained	with	the	combo	RT‐qPCR	(31)	from	NRC‐R	IPP,	used	as	reference	technique.		A	Cohen’s	kappa	coefficient	(k)	of	of	1±0.31	(95%	CI;	0.38‐1.61)		(p=	0.001)	were	obtained.	
Assays	were	also	concordant	with	expected	results	of	interlaboratory	trial	on	the	same	samples.			
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Table	6:	Detection	limit	of	RABV	by	new	established	qRT‐PCR		assays	and	conventional	hemi‐nested	RT‐PCR
TITERS	ID50/mL L	GENE		qRT‐PCR N	GENE	qRT‐PCR Hemi‐nested	PCR
	Mean	Cq	valuea SD 	Mean	Cq	valuea SD Electrophorese	gel	results
6.7E+07 11.00 0.141 15.61 0.820 (+++)
6.7E+06 12.74 0.212 18.08 0.049 (+++)
6.7E+05 15.63 0.346 21.23 0.007 (+++)
6.7E+04 19.57 1.378 24.61 0.60 (++)
6.7E+03 24.58 0.516 28.55 0.381 (++)
6.7E+02 28.51 0.636 31.79 0.622 (++)
6.7E+01 31.74 0.919 36.82 0.021 (+)
6.7 33.51 0.487 39.16 0.487 (+)
0.67 36.63 0.084 Neg Neg Neg
0.067 37.44 0.084 Neg Neg Neg
0.0067 38.07 0.035 Neg Neg Neg
0.00067 38.83 0.254 Neg Neg Neg
0.000067 Neg Neg Neg Neg Neg
Neg:	negative	or	no	fluorescence	signal
Cq	:	quantitative	Cycle	number
a:	Mean	Cq	value	from	duplicates
(+++):	highest	band	intensity
(++):	average	band	intensity
(+):	lowest	band	intensity
Ten	fold‐serial	dilutions	of	RABV	isolate	SA217695SEN	with	an	initial	virus	titer	of	6.7	107	ID50/mL	were	tested	with	new	assays.	The	reference	technique	were
the	RT‐hnPCR	previously	described	(22).
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Table	7:	Clinical	sensibility	assessment	on	intra‐vitam 	human	speciemens	
Patient	Code	 Origin Hospital	service Sample Technique NRC‐R	IPP	combo	RT‐
qPCR		
NRC‐R	IPD	L‐gene	
assay	
Final	diagnosis
H14‐0004 France 			CHU	Mondor Cerebro‐spinal	fluid qRT‐PCR Negative Negative
H14‐0004 France 				CHU	Mondor Skin	biospy													 qRT‐PCR Positive Positive
H14‐0004 France 				CHU	Mondor Saliva	day1																													 qRT‐PCR Negative Negative
H14‐0004 France 				CHU	Mondor Saliva	day2																														 qRT‐PCR Negative Negative RABV‐positive	patient
H14‐0004 France 				CHU	Mondor Saliva	day3																											 qRT‐PCR Negative Negative
H14‐0004 France 				CHU	Mondor Saliva	day4																												 qRT‐PCR Negative Negative
H14‐0004 France 				CHU	Mondor Saliva	day6																								 qRT‐PCR Negative Negative
H14‐0004 France 				CHU	Mondor Saliva	day8																									 qRT‐PCR Negative Negative
H14‐0007 Italia 	CHU	Milan	 Skin	biospy													 qRT‐PCR Positive Positive
H14‐0007 Italia 	CHU	Milan	 Cerebro‐spinal	fluid	day1 qRT‐PCR Positive Positive RABV‐positive	patient
H14‐0007 Italia 	CHU	Milan	 Cerebro‐spinal	fluid	day2 qRT‐PCR Positive Positive
H14‐0008 France 		CH	Garches Skin	biospy													 qRT‐PCR Negative Negative
RABV‐negative	patient
H14‐0008 France 	CH	Garches Saliva					 qRT‐PCR Negative Negative
H14‐0009 France CH	Bastia Skin	biospy													 qRT‐PCR Negative Negative
RABV‐negative	patient
H14‐0009 France CH	Bastia Cerebro‐spinal	fluid qRT‐PCR Negative Negative
H14‐0010 France CHU	Cayenne	 Skin	biospy													 qRT‐PCR Negative Negative
RABV‐negative	patient
H14‐0010 France CHU	Cayenne	 Saliva					 qRT‐PCR Negative Negative
H14‐0011 France CHU	Cayenne Biospy	skin												 qRT‐PCR Negative Negative
RABV‐negative	patient
H14‐0011 France CHU	Cayenne Saliva											 qRT‐PCR Negative Negative
RABV:	rabies	virus
	NRC‐R	IPD	L‐gene	assay	were	100%	concordant	to	the	previous	diagnosis	results	obtained	with	the	combo	RT‐qPCR	(31)	from	NRC‐R	IPP,	used	as	reference	technique.			
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Two reliable real-time quantitative RT-PCR assays were developed for RABV detection 594 
Primer and probe sets were targeted to highly conserved regions in nucleoprotein and 595 
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